Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Johnson and Johnson
Merck
AstraZeneca
Dow

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

SOLTAMOX Drug Profile

See Plans and Pricing

« Back to Dashboard

Which patents cover Soltamox, and when can generic versions of Soltamox launch?

Soltamox is a drug marketed by Fortovia and is included in one NDA.

The generic ingredient in SOLTAMOX is tamoxifen citrate. There are sixteen drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the tamoxifen citrate profile page.

Drug patent expirations by year for SOLTAMOX
Drug Prices for SOLTAMOX

See drug prices for SOLTAMOX

Recent Clinical Trials for SOLTAMOX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
PfizerPhase 2
Emory UniversityPhase 2
National Cancer Institute (NCI)Phase 4

See all SOLTAMOX clinical trials

Pharmacology for SOLTAMOX
Synonyms for SOLTAMOX
(2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}ethyl)dimethylamine
(E/Z)-Tamoxifen
(Z)-1-(p-Dimethylaminoethoxyphenyl)-1,2-diphenyl-1-butene, trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
(Z)-2-(4-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethan-1-amine
(Z)-2-(4-(1,2-diphenylbut-1-en-1-yl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(4-(1,2-diphenylbut-1-enyl)phenoxy)-N,N-dimethylethanamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine
(Z)-2-(para-(1,2-Diphenyl-1-butenyl)phenoxy)-N,N-dimethylamine (IUPAC)
(Z)-2-[4-(1,2)-DIPHENYL-1-BUTENYL)-PHENOXY]-N,N-DIMETHYLETHANAMINE
(Z)-2-[p-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
[3H]-tamoxifen
[3H]tamoxifen
094ZI81Y45
1-[4-(2-Dimethylaminoethoxy)phenyl]-1,2-diphenyl-1-butene
1-p-.beta.-Dimethylamino-ethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-p-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
1-para-beta-Dimethylaminoethoxyphenyl-trans-1,2-diphenylbut-1-ene
10331-EP2270008A1
10331-EP2270018A1
10331-EP2272827A1
10331-EP2272832A1
10331-EP2275102A1
10331-EP2277865A1
10331-EP2277876A1
10331-EP2280012A2
10331-EP2281815A1
10331-EP2289892A1
10331-EP2292233A2
10331-EP2292576A2
10331-EP2292614A1
10331-EP2292617A1
10331-EP2295416A2
10331-EP2295426A1
10331-EP2295427A1
10331-EP2298305A1
10331-EP2298746A1
10331-EP2298748A2
10331-EP2298778A1
10331-EP2298780A1
10331-EP2301536A1
10331-EP2301538A1
10331-EP2301933A1
10331-EP2305640A2
10331-EP2305642A2
10331-EP2305671A1
10331-EP2305689A1
10331-EP2308833A2
10331-EP2308855A1
10331-EP2308861A1
10331-EP2311455A1
10331-EP2311825A1
10331-EP2311827A1
10331-EP2311840A1
10331-EP2311842A2
10331-EP2316452A1
10331-EP2316831A1
10331-EP2316832A1
10331-EP2316833A1
10331-EP2316834A1
10331-EP2374454A1
10540-29-1
13002-65-8
1ya4
2-[4-[(1Z)-1,2-Diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethylethanamine
2-[4-[(Z)-1,2-di(phenyl)but-1-enyl]phenoxy]-N,N-dimethylethanamine
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethyl-ethanamine
2-[4-[(Z)-1,2-diphenylbut-1-enyl]phenoxy]-N,N-dimethylethanamine
2-[4-[1,2-di(phenyl)but-1-enyl]phenoxy]-n,n-dimethylethanamine
2-{4-[(1Z)-1,2-diphenylbut-1-en-1-yl]phenoxy}-N,N-dimethylethanamine
2060AH
540T291
54965-24-1 (citrate)
7728-73-6
A801229
AB00053547_19
AB00053547_20
AB00053547-16
AB00053547-17
AB00053547-18
AC1MBZ3R
AJ-26679
AKOS022143035
AM84324
AOB5640
AX8001839
B5965
BDBM20607
BIDD:ER0008
BIDD:GT0009
BIDD:PXR0003
BPBio1_000278
BRD-K93754473-001-02-9
BRD-K93754473-048-04-6
BRD-K93754473-048-05-3
BRD-K93754473-048-10-3
BSPBio_000252
BSPBio_001150
BSPBio_001982
C07108
C26H29NO
CAS-10540-29-1
CCG-205277
CCRIS 3275
CHEBI:41774
CHEMBL83
cid_2733526
Citofen
cMAP_000044
Crisafeno
CS-2870
D08559
DB00675
Diemon
DSSTox_CID_14187
DSSTox_GSID_34187
DSSTox_RID_79121
DTXSID1034187
EBD41546
EC 234-118-0
EINECS 234-118-0
Ethanamine, 2-(4-((1Z)-1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-
Ethanamine, 2-(4-(1,2-diphenyl-1-butenyl)phenoxy)-N,N-dimethyl-, (Z)-
Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-buten-1-yl]phenoxy]-N,N-dimethyl-
Ethanamine, 2-[4-[(1Z)-1,2-diphenyl-1-butenyl]phenoxy]-N,N-dimethyl-
Ethylamine, N,N-dimethyl-2-(p-(1,2-diphenyl-1-butenyl)phenoxy)-, (Z)-
GA9513
Gen-Tamoxifen
GTPL1016
GTPL5384
HMS1362J11
HMS1792J11
HMS1990J11
HMS2090N08
HMS2232C12
HMS3261D09
HMS3403J11
HSDB 6782
HY-13757A
ICI 47699
ICI-46,474
ICI-46474
ICI-47699
IDI1_000258
IDI1_002170
Istubol
KB-282403
KB-80805
KS-1472
L024126
Lopac0_001203
LP00494
LS-393
MFCD00010454
MLS001332535
MLS001332536
NCGC00024928-01
NCGC00024928-03
NCGC00024928-04
NCGC00024928-05
NCGC00024928-07
NCGC00024928-08
NCGC00024928-09
NCGC00024928-10
NCGC00024928-11
NCGC00024928-12
NCGC00024928-13
NCGC00024928-14
NCGC00024928-15
NCGC00024928-16
NCGC00024928-17
NCGC00024928-18
NCGC00024928-19
NCGC00254455-01
NCGC00258795-01
NCGC00261179-01
NKANXQFJJICGDU-QPLCGJKRSA-N
Nolvadex-D
Nourytam
Novaldex
Novo-Tamoxifen
NSC-727681
NSC727681
Oncomox
Pms-Tamoxifen
Prestwick2_000146
Prestwick3_000146
QTL1_000079
Retaxim
SBI-0051170.P004
SC-45564
SCHEMBL4084
SMR000059172
Spectrum5_001417
Spectrum5_002043
ST24049322
ST24049323
Tamizam
Tamone
Tamoplex (TN)
Tamoxen
tamoxifen
Tamoxifen (INN)
TAMOXIFEN (TAMOXIFEN CITRATE (54965-24-1))
Tamoxifen (TN)
Tamoxifen (Z)
Tamoxifen [INN:BAN]
Tamoxifen and its salts
Tamoxifen Drug Standard Solution
Tamoxifen, >=99%
Tamoxifen, 7
Tamoxifen, analytical standard
Tamoxifen, certified reference material, TraceCERT(R)
Tamoxifene
Tamoxifene [INN-French]
Tamoxifeno
Tamoxifeno [INN-Spanish]
Tamoxifenum
Tamoxifenum [INN-Latin]
Tocris-0999
Tomaxithen
Tox21_201243
Tox21_300539
Tox21_500494
TRANS FORM OF TAMOXIFEN
trans-2-[4-(1,2-Diphenyl-1-butenyl)phenoxy]-N,N-dimethylethylamine
trans-Tamoxifen
UNII-094ZI81Y45
UPCMLD-DP027
VA11813
Valodex
W-108788
ZINC1530689

US Patents and Regulatory Information for SOLTAMOX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fortovia SOLTAMOX tamoxifen citrate SOLUTION;ORAL 021807-001 Oct 29, 2005 RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Medtronic
Harvard Business School
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.